A comparison of diabetic polyneuropathy in Type II diabetic BBZDR/Wor rats and in Type I diabetic BB/Wor rats
- 6 June 2000
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 43 (6) , 786-793
- https://doi.org/10.1007/s001250051376
Abstract
Aims/hypothesis. To examine the functional, metabolic and structural abnormalities in peripheral nerve in the spontaneously Type II (non-insulin-dependent) diabetic BBZDR/Wor rat and compare these data with those in the Type I (insulin-dependent) diabetic BB/Wor rat.¶Methods. Animals were examined at 6 and 14 months of diabetes. Nerve conduction velocity was measured longitudinally. Nerve polyols were analysed using gas liquid chromatography and Na/K+-ATPase activity was measured enzymatically. Light and electron microscopic techniques were used for nerve morphometry.¶Results. Diabetic BBZDR/Wor rats showed a slowly progressive nerve conduction defect that reached 17 % (p < 0.01) at 14 months. There was a decrease in Na+/K+-ATPase of 35 % (p < 0.05). Structurally, there were mild myelinated fibre atrophy (p < 0.05), mild or absent changes of the node of Ranvier, but significant (p < 0.001) segmental demyelination and Wallerian degeneration. These findings point to a more severe nerve conduction defect, severe myelinated fibre atrophy and profound nodal changes in Type I spontaneously diabetic BB/Wor rats maintained at the same hyperglycaemic concentrations.¶Conclusion/interpretation. We conclude that other factors, beside hyperglycaemia, are involved in the pathogenesis of the more severe Type I diabetic neuropathy which possibly involve insulin and C-peptide deficiencies. [Diabetologia (2000) 43: 786–793]Keywords
This publication has 13 references indexed in Scilit:
- Specific binding of proinsulin C-peptide to human cell membranesProceedings of the National Academy of Sciences, 1999
- Experimental diabetic neuropathy: an updateDiabetologia, 1999
- Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy.Journal of Clinical Investigation, 1988
- Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol.Journal of Clinical Investigation, 1987
- Aldose reductase in the BB rat: isolation, immunological identification and localization in the retina and peripheral nerveDiabetologia, 1987
- Infusion of synthetic human C-peptide does not affect plasma glucose, serum insulin, or plasma glucagon in healthy subjectsMetabolism, 1986
- Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat.Journal of Clinical Investigation, 1986
- Insulin and insulin-like growth factor II permit nerve growth factor binding and the neurite formation response in cultured human neuroblastoma cells.Proceedings of the National Academy of Sciences, 1984
- Axonal atrophy in sensory nerves of the diabetic BB‐Wistar rat: A possible early correlate of human diabetic neuropathyAnnals of Neurology, 1983
- Changes in nodal function in nerve fibres of the spontaneously diabetic BB‐Wistar rat: Potential clamp analysisActa Physiologica Scandinavica, 1981